CYCLIN E1 AS A THERAPEUTIC TARGET IN WOMEN WITH HIGH-GRADE SEROUS OVARIAN CANCER AND PRIMARY TREATMENT FAILURE.

University Of Melbourne, Melbourne

Investigators